A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

NCT06533059 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Breast Cancer
Endometrial Cancer
Metastatic Cancer
Advanced Solid Tumor

Interventions

DRUG: ALTA2618

Sponsor

Alterome Therapeutics, Inc.